Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant shape » significant change (Expand Search), significant gap (Expand Search), significant short (Expand Search)
significant side » significant sex (Expand Search), significant burden (Expand Search), significant source (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant shape » significant change (Expand Search), significant gap (Expand Search), significant short (Expand Search)
significant side » significant sex (Expand Search), significant burden (Expand Search), significant source (Expand Search)
-
3681
-
3682
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
3683
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
3684
-
3685
-
3686
-
3687
-
3688
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3689
-
3690
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3691
-
3692
-
3693
-
3694
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3695
-
3696
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3697
Relative abundance of microbiota in colonic content at the genus level (n = 5).
Published 2025Subjects: -
3698
-
3699
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3700
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: